SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-238256
Filing Date
2012-05-17
Accepted
2012-05-17 16:04:00
Documents
8
Period of Report
2012-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d352609d8k.htm 8-K 24941
2 UNDERWRITING AGREEMENT d352609dex11.htm EX-1.1 152979
3 OPINION OF COOLEY LLP d352609dex51.htm EX-5.1 7810
4 ARENA PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK d352609dex991.htm EX-99.1 9986
5 ARENA PHARMACEUTICALS PRICES PUBLIC OFFERING OF COMMON STOCK d352609dex992.htm EX-99.2 11273
6 GRAPHIC g352609g20u31.jpg GRAPHIC 4159
7 GRAPHIC g352609image01.jpg GRAPHIC 5056
8 GRAPHIC g352609image02.jpg GRAPHIC 7248
  Complete submission text file 0001193125-12-238256.txt   231183
Mailing Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121 8584537200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 12851995
SIC: 2834 Pharmaceutical Preparations